N-Descyclopropanecarbaldehyde Olaparib |
Catalog No.GC62154 |
N-descyclopropanecarbaldéhyde L'olaparib est un analogue de l'olaparib contenant le fragment DOTA. Le N-descyclopropanecarbaldéhyde Olaparib est un ligand À base de CRBN pour la synthèse du nouveau double EGFR et PARP PROTAC, DP-C-4. N-Descyclopropanecarbaldéhyde L'olaparib peut être radiomarqué au F-18 ou au fluorophore pour la tomographie par émission de positrons (TEP) ou l'imagerie optique dans plusieurs types de tumeurs.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 763111-47-3
Sample solution is provided at 25 µL, 10mM.
N-Descyclopropanecarbaldehyde Olaparib is an analogue of Olaparib containing DOTA moiety. N-Descyclopropanecarbaldehyde Olaparib is a CRBN-based ligand for synthesizing novel dual EGFR and PARP PROTAC, DP-C-4[1]. N-Descyclopropanecarbaldehyde Olaparib can be radiolabeled F-18 or fluorophore for positron emission tomography (PET) or optical imaging in several types of tumor[2].
[1]. Tao Huang, et al. Initial evaluation of Cu-64 labeled PARPi-DOTA PET imaging in mice with mesothelioma. Bioorg Med Chem Lett. 2017 Aug 1;27(15):3472-3476.
[2]. Mengzhu Zheng, et al. Rational Design and Synthesis of Novel Dual PROTACs for Simultaneous Degradation of EGFR and PARP. J Med Chem. 2021 May 26.
Average Rating: 5
(Based on Reviews and 5 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *